NCT01993667View on ClinicalTrials.gov

Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Prophylaxis of Acute Mountain Sickness
Interventions
DRUG

Low Dose Acetazolamide

Administration of low dose acetazolamide

DRUG

Normal Dose Acetazolamide

Administration of normal dose acetazolamide

Trial Locations (1)

84132

University of Utah Health Sciences Center, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT01993667 - Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing | Biotech Hunter | Biotech Hunter